No Data
No Data
10 Health Care Stocks Whale Activity In Today's Session
Earnings Preview: TGTX to Report Financial Results Pre-market on March 03
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
Institutional Investors in TG Therapeutics, Inc. (NASDAQ:TGTX) See US$243m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
TG Therapeutics Announces Presentation Schedule for BRIUMVI Data at ACTRIMS 2025 Conference
Express News | TG Therapeutics Announces Schedule of Data Presentations for Briumvi® (Ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum